Supplementary Financial Information (unaudited) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | 12 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 30, 2017 |
Sep. 30, 2017 |
Jul. 01, 2017 |
Apr. 01, 2017 |
Dec. 31, 2016 |
Sep. 24, 2016 |
Jun. 25, 2016 |
Mar. 26, 2016 |
Dec. 30, 2017 |
Dec. 31, 2016 |
Dec. 26, 2015 |
Apr. 29, 2016 |
|
| Quarterly Financial Information Disclosure [Abstract] | ||||||||||||
| Net revenue | $ 1,480 | $ 1,643 | $ 1,222 | $ 984 | $ 1,106 | $ 1,307 | $ 1,027 | $ 832 | $ 5,329 | $ 4,272 | $ 3,991 | |
| Cost of sales | 965 | 1,070 | 818 | 653 | 755 | 1,248 | 708 | 563 | 3,506 | 3,274 | 2,911 | |
| Gross margin | 515 | 573 | 404 | 331 | 351 | 59 | 319 | 269 | 1,823 | 998 | 1,080 | |
| Research and development | 300 | 315 | 279 | 266 | 264 | 259 | 243 | 242 | 1,160 | 1,008 | 947 | |
| Marketing, general and administrative | 133 | 132 | 125 | 121 | 121 | 117 | 117 | 105 | 511 | 460 | 482 | |
| Restructuring and other special charges (reversals), net | 0 | 0 | 0 | 0 | 0 | 0 | (7) | (3) | 0 | (10) | 129 | |
| Licensing gain | 0 | 0 | (25) | (27) | (31) | (24) | (26) | (7) | (52) | (88) | 0 | |
| Operating income (loss) | 82 | 126 | 25 | (29) | (3) | (293) | (8) | (68) | 204 | (372) | (481) | |
| Interest expense | (31) | (31) | (32) | (32) | (34) | (41) | (41) | (40) | (126) | (156) | (160) | |
| Other income (expense), net | 2 | (3) | (3) | (5) | (7) | (63) | 150 | 0 | (9) | 80 | (5) | |
| Income (loss) before income taxes | 53 | 92 | (10) | (66) | (44) | (397) | 101 | (108) | 62 | (458) | (646) | |
| Provision for income taxes | (8) | 19 | 3 | 5 | 5 | 4 | 29 | 1 | 19 | 39 | 14 | |
| Equity loss in investee | 0 | (2) | (3) | (2) | (2) | (5) | (3) | 0 | (7) | (10) | 0 | |
| Net income (loss) | $ 61 | $ 71 | $ (16) | $ (73) | $ (51) | $ (406) | $ 69 | $ (109) | $ 43 | $ (497) | $ (660) | |
| Earnings (loss) per share | ||||||||||||
| Basic (USD per share) | $ 0.06 | $ 0.07 | $ (0.02) | $ (0.08) | $ (0.06) | $ (0.50) | $ 0.09 | $ (0.14) | $ 0.04 | $ (0.60) | $ (0.84) | |
| Diluted (USD per share) | $ 0.06 | $ 0.07 | $ (0.02) | $ (0.08) | $ (0.06) | $ (0.50) | $ 0.08 | $ (0.14) | $ 0.04 | $ (0.60) | $ (0.84) | |
| Shares used in per share calculation | ||||||||||||
| Basic (shares) | 965 | 957 | 945 | 939 | 931 | 815 | 794 | 793 | 952 | 835 | 783 | |
| Diluted (shares) | 1,037 | 1,042 | 945 | 939 | 931 | 815 | 821 | 793 | 1,039 | 835 | 783 | |
| Schedule of Equity Method Investments [Line Items] | ||||||||||||
| Net gain on sale of equity interests | $ 3 | $ 146 | $ 0 | |||||||||
| Affiliated Entity | ||||||||||||
| Schedule of Equity Method Investments [Line Items] | ||||||||||||
| Charge related to the Sixth Amendment to the WSA with GF | 340 | |||||||||||
| ATMP JV | ||||||||||||
| Schedule of Equity Method Investments [Line Items] | ||||||||||||
| Net gain on sale of equity interests | $ 3 | $ (4) | $ 150 | |||||||||
| TFME’s Affiliates | ||||||||||||
| Schedule of Equity Method Investments [Line Items] | ||||||||||||
| Equity interest in each JV | 85.00% | |||||||||||
| Limited Waiver | Affiliated Entity | ||||||||||||
| Schedule of Equity Method Investments [Line Items] | ||||||||||||
| Charge related to the Sixth Amendment to the WSA with GF | 100 | |||||||||||
| WCH | Affiliated Entity | ||||||||||||
| Schedule of Equity Method Investments [Line Items] | ||||||||||||
| Charge related to the Sixth Amendment to the WSA with GF | $ 240 | |||||||||||
| X | ||||||||||
- Definition Restructuring and other special charges, net No definition available.
|
| X | ||||||||||
- Definition Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of the gain (loss) recognized by the parent and included in its attributable portion of net income for the period due to deconsolidation of a subsidiary or derecognition of a group of assets. The gain (loss) recognized and included in the net income attributable to the parent for the period is generally computed as the difference between: (a) the aggregate of: (1) the fair value of any consideration received; (2) the fair value of any retained noncontrolling investment in the former subsidiary at the date the subsidiary was deconsolidated; and (3) the carrying amount of any noncontrolling interest in the former subsidiary (including any accumulated other comprehensive income attributable to the noncontrolling interest) at the date the subsidiary was deconsolidated and (b) the carrying amount of the former subsidiary's assets and liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of other expense (income) that is infrequent in occurrence or unusual in nature. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|